Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the effectiveness and safety of TD 4208, an
investigational drug being developed to treat people with moderate to very severe COPD,
compared to placebo, a treatment without activity.